aztreonam has been researched along with Infections, Proteus in 8 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "10 patients with meningitis due to unusual gram-negative organisms (Pseudomonas, Proteus, Salmonella and Klebsiella) were effectively treated with aztreonam." | 7.68 | Aztreonam for treating meningitis caused by gram-negative rods. ( Bishay, E; Farid, Z; Girgis, N; Kilpatrick, M, 1991) |
| "10 patients with meningitis due to unusual gram-negative organisms (Pseudomonas, Proteus, Salmonella and Klebsiella) were effectively treated with aztreonam." | 3.68 | Aztreonam for treating meningitis caused by gram-negative rods. ( Bishay, E; Farid, Z; Girgis, N; Kilpatrick, M, 1991) |
| "Aztreonam is a novel antimicrobial agent belonging to the monobactam class of antibiotics." | 1.27 | Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa. ( Neu, HC; Scully, BE, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Protonotariou, E | 1 |
| Poulou, A | 1 |
| Politi, L | 1 |
| Meletis, G | 1 |
| Chatzopoulou, F | 1 |
| Malousi, A | 1 |
| Metallidis, S | 1 |
| Tsakris, A | 1 |
| Skoura, L | 1 |
| Wang, JT | 1 |
| Chen, PC | 1 |
| Chang, SC | 1 |
| Shiau, YR | 1 |
| Wang, HY | 1 |
| Lai, JF | 1 |
| Huang, IW | 1 |
| Tan, MC | 1 |
| Lauderdale, TL | 1 |
| Dixon, N | 1 |
| Fowler, RC | 1 |
| Yoshizumi, A | 1 |
| Horiyama, T | 1 |
| Ishii, Y | 1 |
| Harrison, L | 1 |
| Geyer, CN | 1 |
| Moland, ES | 1 |
| Thomson, K | 1 |
| Hanson, ND | 1 |
| Perilli, M | 1 |
| Segatore, B | 1 |
| De Massis, MR | 1 |
| Franceschini, N | 1 |
| Bianchi, C | 1 |
| Rossolini, GM | 1 |
| Amicosante, G | 1 |
| Fayed, DF | 1 |
| Dahmash, NS | 1 |
| Saddique, AA | 1 |
| Shibl, AM | 1 |
| Gomez-Alferez, A | 1 |
| Baquero, F | 1 |
| Canton, R | 1 |
| Loza, E | 1 |
| Martinez-Beltran, J | 1 |
| Kilpatrick, M | 1 |
| Girgis, N | 1 |
| Farid, Z | 1 |
| Bishay, E | 1 |
| Scully, BE | 1 |
| Neu, HC | 1 |
1 trial available for aztreonam and Infections, Proteus
| Article | Year |
|---|---|
Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aztreonam; Bacteremia; Citrobacter; Cross Infection; | 1992 |
7 other studies available for aztreonam and Infections, Proteus
| Article | Year |
|---|---|
Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Re | 2020 |
Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; be | 2014 |
IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis.
Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Hydrol | 2016 |
Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey.
Topics: Aztreonam; beta-Lactamases; Cephalosporins; Escherichia coli; Humans; Italy; Kinetics; Molecular Seq | 2002 |
The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactamases; Cephalosporins | 1991 |
Aztreonam for treating meningitis caused by gram-negative rods.
Topics: Adult; Aztreonam; Bacterial Infections; Child; Child, Preschool; Female; Gram-Negative Bacteria; Hum | 1991 |
Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infectio | 1985 |